Publications by authors named "N Teeratakulpisarn"

Background: Corticosteroids are commonly used to treat COVID-19 patients with hypoxemia, and clinicians have adjusted the corticosteroid intensity on the basis of clinical needs. However, neither the optimal dose nor the duration of treatment has been recommended.

Objective: To investigate whether cumulative doses of corticosteroids, measured as dexamethasone-equivalent doses over the first 14 days, impact outcomes in patients with COVID-19 pneumonia.

View Article and Find Full Text PDF

The evidence supporting additional hemoperfusion (HP) with cytokine adsorbents for improving clinical outcomes in severe to critical coronavirus disease 2019 (COVID-19) patients remains limited. We compared severe to critical COVID-19 patients who received additional HP with a cytokine adsorbent to matched cases receiving standard medical treatment (SMT). The primary outcome was hospital mortality.

View Article and Find Full Text PDF
Article Synopsis
  • MSM living with HIV have a higher risk for anal cancer, particularly due to precursor lesions called high-grade squamous intraepithelial lesions (HSILs), but the incidence among those starting antiretroviral therapy during acute HIV has not been well studied.* -
  • In a study of 89 MSM and 4 transgender women in Bangkok, 11.8% were found to have anal HSIL at the start, with an incidence rate of 19.7 per 100 person-years, influenced by factors like specific HPV types and syphilis.* -
  • The study concluded that while the prevalence of anal HSIL was similar among those initiating treatment during acute HIV and those without HIV, ongoing screening and management
View Article and Find Full Text PDF

Background: Females with perinatal HIV (PHIV) infection are at elevated risk for anogenital high-risk human papillomavirus (HR-HPV) infection. Limited data are available around the effect of the HPV vaccination after initiation of sexual activity among PHIV youth. This study aims to assess the impact of a bivalent HPV vaccination on the persistence of anogenital HR-HPV among sexually active female PHIV youth and matched HIV-negative controls aged 12-24years in Thailand and Vietnam.

View Article and Find Full Text PDF

Purpose: Feminizing hormone therapy (FHT) is used by many transgender women as a pharmacological method to mitigate gender dysphoria. However, information on hormone concentrations among those who use FHT is lacking. We aimed to determine the proportion of Thai transgender women who were using FHT who had hormone concentrations within target ranges in a real-world clinic setting.

View Article and Find Full Text PDF